Chuan‐Ming Xie

机构：Army Medical University, Southwest Hospital · ORCID：0000-0003-4362-6612

发表论文 61 篇 · 总被引 1927 次 · h-index 24

代表论文

• Cancer type classification using plasma cell-free RNAs derived from human and microbes (2022 · eLife · 被引 72)
• Integrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese population (2024 · Science Translational Medicine · 被引 42)
• Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice (2023 · Experimental & Molecular Medicine · 被引 32)
• Elevated FBXL6 activates both wild-type KRAS and mutant KRASG12D and drives HCC tumorigenesis via the ERK/mTOR/PRELID2/ROS axis in mice (2023 · Military Medical Research · 被引 31)
• Mutant Kras and mTOR crosstalk drives hepatocellular carcinoma development via PEG3/STAT3/BEX2 signaling (2022 · Theranostics · 被引 27)
• Elevated expression of WSB2 degrades p53 and activates the IGFBP3-AKT-mTOR-dependent pathway to drive hepatocellular carcinoma (2024 · Experimental & Molecular Medicine · 被引 26)